NeuroMetrix IncNASDAQ:NURO
- LAST PRICE4.3300
- TODAY'S CHANGE (%)0.6800 (18.6301%)
- Bid / Lots4.3000/ 30
- Ask / Lots4.4900/ 2
- Open / Previous Close3.9200 / 3.6500
- Day Range
- 52 Week Range
- Volume254,830
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NURO |
|---|---|---|
| 09:32 ET | 1600 | 4 |
| 09:36 ET | 5829 | 4.04 |
| 09:38 ET | 10108 | 4.12 |
| 09:39 ET | 3087 | 4.125 |
| 09:41 ET | 6795 | 4.1699 |
| 09:43 ET | 15799 | 4.3921 |
| 09:45 ET | 9509 | 4.3197 |
| 09:48 ET | 1626 | 4.13 |
| 09:50 ET | 284 | 4.2608 |
| 09:52 ET | 2200 | 4.21 |
| 09:54 ET | 4810 | 4.05 |
| 09:56 ET | 400 | 4.15 |
| 10:03 ET | 1717 | 4.1157 |
| 10:06 ET | 2552 | 4.2 |
| 10:08 ET | 3628 | 4.16 |
| 10:10 ET | 500 | 4.198 |
| 10:12 ET | 2396 | 4.1 |
| 10:14 ET | 700 | 4.15 |
| 10:15 ET | 2500 | 4.15 |
| 10:21 ET | 786 | 4.1 |
| 10:24 ET | 1044 | 4.15 |
| 10:26 ET | 800 | 4.1802 |
| 10:28 ET | 1676 | 4.22 |
| 10:30 ET | 4724 | 4.36 |
| 10:32 ET | 3600 | 4.326 |
| 10:33 ET | 915 | 4.3399 |
| 10:35 ET | 500 | 4.3399 |
| 10:42 ET | 400 | 4.2982 |
| 10:44 ET | 314 | 4.27 |
| 11:02 ET | 1485 | 4.25 |
| 11:04 ET | 2249 | 4.2502 |
| 11:13 ET | 4429 | 4.22 |
| 11:15 ET | 500 | 4.2952 |
| 11:18 ET | 800 | 4.37 |
| 11:20 ET | 2800 | 4.3319 |
| 11:22 ET | 100 | 4.3674 |
| 11:24 ET | 3585 | 4.31 |
| 11:26 ET | 623 | 4.315 |
| 11:29 ET | 100 | 4.3979 |
| 11:33 ET | 100 | 4.295 |
| 11:36 ET | 870 | 4.3804 |
| 11:38 ET | 410 | 4.3 |
| 11:45 ET | 100 | 4.3999 |
| 11:47 ET | 100 | 4.3999 |
| 11:51 ET | 492 | 4.285 |
| 12:00 ET | 2086 | 4.2675 |
| 12:02 ET | 4070 | 4.1901 |
| 12:07 ET | 12813 | 4.15 |
| 12:09 ET | 200 | 4.35 |
| 12:20 ET | 320 | 4.17 |
| 12:21 ET | 1825 | 4.3205 |
| 12:27 ET | 100 | 4.2815 |
| 12:34 ET | 200 | 4.28 |
| 12:38 ET | 200 | 4.2799 |
| 12:39 ET | 1319 | 4.26 |
| 12:41 ET | 300 | 4.3499 |
| 12:43 ET | 333 | 4.26 |
| 12:45 ET | 1079 | 4.334 |
| 12:48 ET | 100 | 4.3183 |
| 12:50 ET | 1097 | 4.2 |
| 12:52 ET | 1770 | 4.21 |
| 12:56 ET | 200 | 4.25 |
| 01:01 ET | 1100 | 4.25 |
| 01:03 ET | 400 | 4.2065 |
| 01:08 ET | 319 | 4.24 |
| 01:10 ET | 233 | 4.25 |
| 01:15 ET | 1000 | 4.2631 |
| 01:17 ET | 200 | 4.29 |
| 01:44 ET | 200 | 4.27 |
| 01:51 ET | 738 | 4.24 |
| 01:57 ET | 743 | 4.23 |
| 02:18 ET | 1500 | 4.27 |
| 02:20 ET | 6804 | 4.3 |
| 02:22 ET | 1911 | 4.21 |
| 02:24 ET | 281 | 4.34 |
| 02:26 ET | 270 | 4.3309 |
| 02:29 ET | 9000 | 4.2515 |
| 02:42 ET | 167 | 4.33 |
| 02:47 ET | 406 | 4.21 |
| 02:49 ET | 4286 | 4.38 |
| 02:56 ET | 2067 | 4.4029 |
| 02:58 ET | 732 | 4.35 |
| 03:00 ET | 1026 | 4.375 |
| 03:02 ET | 2865 | 4.3825 |
| 03:05 ET | 1000 | 4.375 |
| 03:07 ET | 115 | 4.35 |
| 03:09 ET | 900 | 4.36 |
| 03:16 ET | 1000 | 4.41 |
| 03:20 ET | 200 | 4.41 |
| 03:23 ET | 100 | 4.39 |
| 03:25 ET | 20285 | 4.2503 |
| 03:27 ET | 4730 | 4.21 |
| 03:36 ET | 2722 | 4.2762 |
| 03:38 ET | 900 | 4.3767 |
| 03:39 ET | 900 | 4.33 |
| 03:41 ET | 1000 | 4.2701 |
| 03:43 ET | 1500 | 4.28 |
| 03:45 ET | 1000 | 4.27 |
| 03:48 ET | 3380 | 4.281 |
| 03:50 ET | 1000 | 4.31 |
| 03:52 ET | 500 | 4.294 |
| 03:56 ET | 1400 | 4.3134 |
| 03:59 ET | 10162 | 4.33 |
Yesterday
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
NeuroMetrix Inc | 8.6M | -0.7x | --- |
Biomerica Inc | 12.3M | -1.9x | --- |
Encision Inc | 5.1M | -11.4x | --- |
Pressure Biosciences Inc | 5.6M | -0.2x | --- |
Sigyn Therapeutics Inc | 7.0M | -1.5x | --- |
Predictive Oncology Inc | 4.8M | -0.3x | --- |
Company Information
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. It operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.
Contact Information
- Headquarters
- 1000 Winter StreetWALTHAM, MA, United States 02451
- Phone
- 781-890-9989
- Fax
- 302-636-5454
Executives
- Chairman of the Board, President, Chief Executive Officer, Secretary
- Shai Gozani
- Chief Financial Officer, Senior Vice President, Treasurer
- Thomas Higgins
- Independent Director
- Bradley Fluegel
- Independent Director
- David Goodman
- Independent Director
- Nancy Katz
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.6M |
|---|---|
Revenue (TTM) | $5.9M |
Shares Outstanding | 2.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.26 |
EPS | $-6.29 |
Book Value | $13.18 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -121.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
